Dedicated to improving the health of individuals living with serious conditions.

Built upon a rich legacy of innovative “firsts,” Janssen Biotech, Inc. continues to redefine the standard of care in the therapeutic areas of immunology, oncology and nephrology.

Janssen Biotech was acquired by Johnson & Johnson.

Sector: Healthcare

Status: Alumni